DocSym
β
Searchsearch
Search
(Y51.0) Anticholinesterase agents
More details coming soon
17 073 in individuals diagnosis anticholinesterase agents confirmed
507 deaths with diagnosis anticholinesterase agents
3% mortality rate associated with the disease anticholinesterase agents
Diagnosis anticholinesterase agents is diagnosed Men are 43.77% more likely than Women
12 273
Men receive the diagnosis anticholinesterase agents
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
4 800
Women receive the diagnosis anticholinesterase agents
507 (10.6 %)Died from this diagnosis.
Risk Group for the Disease anticholinesterase agents - Men aged 70-74 and Women aged 50-54
In Men diagnosis is most often set at age 0-5, 35-39, 50-84
Less common in men the disease occurs at Age 0-1, 5-34, 40-49, 85-95+Less common in women the disease occurs at Age 0-29, 35-49, 55-69, 75-79, 85-95+
In Women diagnosis is most often set at age 30-34, 50-54, 70-74, 80-84
Disease Features anticholinesterase agents
Absence or low individual and public risk
Anticholinesterase agents - what does this mean
Anticholinesterase agents are drugs that interfere with the action of the enzyme acetylcholinesterase, which breaks down the neurotransmitter acetylcholine in the body. this leads to an increase in the level of acetylcholine, which can cause a variety of symptoms such as muscle weakness, blurred vision, and confusion.
What happens during the disease - anticholinesterase agents
Anticholinesterase agents are drugs that inhibit the action of the enzyme acetylcholinesterase, which breaks down the neurotransmitter acetylcholine. this leads to an increase of acetylcholine in the synaptic cleft, resulting in an overexcitation of the post-synaptic neuromuscular junction, causing muscle weakness, fasciculation, and paralysis.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Blood tests
- Urine tests
- Imaging tests (such as X-ray, MRI, CT scan)
- Electrocardiogram (ECG)
- Electromyography (EMG)
- Neuropsychological tests
- Genetic testing
- Lumbar puncture
Treatment and Medical Assistance
Main goal of the treatment: To reduce the symptoms of anticholinesterase agents.
- Prescribe anticholinesterase agents
- Monitor the patient’s response to the treatment
- Adjust the dosage as needed
- Provide lifestyle modifications, such as a healthy diet and exercise
- Recommend alternative treatments, such as cognitive behavioral therapy
- Educate the patient about the disease and its management
- Refer the patient to other specialists as needed
8 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Anticholinesterase agents - Prevention
Anticholinesterase agents should be avoided in order to prevent the development of the disease. these agents can interfere with the body's natural ability to break down acetylcholine, leading to an accumulation of the neurotransmitter in the body and resulting in various conditions related to overstimulation of the nervous system. in addition, individuals should be aware of potential environmental sources of anticholinesterase agents, such as pesticides and herbicides, and take appropriate steps to limit their exposure.